Mariner, LLC Nkarta, Inc. Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Mariner, LLC holds 12,529 shares of NKTX stock, worth $31,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,529

Previous 13,578 7.73%

Holding current value

$31,071

Previous $80,000 30.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.52 - $8.0 $4,741 - $8,392	-1,049 Reduced 7.73%	12,529 $56,000
Q2 2024 Aug 13, 2024	BUY	$5.27 - $10.82 $843 - $1,731	160 Added 1.19%	13,578 $80,000
Q1 2024 May 15, 2024	SELL	$5.59 - $15.71 $313 - $879	-56 Reduced 0.42%	13,418 $145,000
Q4 2023 Feb 14, 2024	SELL	$1.31 - $6.6 $22,890 - $115,328	-17,474 Reduced 56.46%	13,474 $88,000
Q3 2023 Nov 13, 2023	BUY	$1.39 - $2.29 $14,358 - $23,655	10,330 Added 50.1%	30,948 $43,000
Q2 2023 Aug 11, 2023	BUY	$2.19 - $5.17 $4,270 - $10,081	1,950 Added 10.45%	20,618 $45,000
Q1 2023 May 12, 2023	BUY	$3.37 - $6.3 $62,911 - $117,608	18,668 New	18,668 $66,000

Others Institutions Holding NKTX

# of Institutions

126

Shares Held

66.5M

Call Options Held

173K

Put Options Held

20K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $121M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account